Latest Regulatory Approvals News

New Murchison Gold Limited reports breakthrough ultra-high grade gold intercepts at Crown Prince alongside a robust feasibility study and strong funding position, setting the stage for mid-2025 mining commencement.

Emperor Energy has submitted a key Environmental Plan to NOPSEMA, marking a major step towards drilling the Judith-2 appraisal well in mid-2026 amid tightening east coast gas supply. The company also appointed industry veteran Douglas Jendry as Chairman to steer its next phase.

Terragen Holdings has launched its new probiotic products for ruminants, initiated multiple key trials including methane mitigation and crop yield studies, and secured a US patent allowance, positioning itself for global market expansion.

Zenith Minerals reported a pivotal quarter advancing exploration at its Dulcie Far North and Red Mountain gold projects, while agreeing to divest its Turkish Kavaklitepe interest, sharpening its focus on domestic assets.

EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.

Avenira Limited is advancing its Wonarah Phosphate Project with site mobilisation planned for mid-2025, backed by a $7.567 million capital injection from major shareholder Sichuan Hebang Technology. Operational milestones and regulatory approvals are progressing, positioning the company for first ore shipment in Q4.

Viridis Mining and Minerals has announced a landmark 140% increase in its Colossus Project's rare earth resource, now the largest and highest-grade ionic adsorption clay deposit worldwide. A recent Scoping Study confirms the project's exceptional economics and low-cost profile, positioning it as a global leader in rare earth production.

Highfield Resources has made significant progress on its strategic transaction with Yankuang Energy and Beijing Energy, securing key regulatory approvals and restructuring its financing amid disciplined cost management.

Asra Minerals has completed a comprehensive target generation exercise at its Leonora Gold Projects, identifying 26 priority drill-ready gold targets and securing regulatory approval to commence drilling in Q2 2025. The company also strengthened its balance sheet with a $3 million placement and asset sale proceeds.

Nexus Minerals reports breakthrough regional exploration success at its Wallbrook Gold Project with two new significant gold discoveries and expanded mineralisation footprints, while progressing mine studies and permit applications.

Imagion Biosystems has progressed its MagSense HER2 breast cancer imaging agent towards a pivotal Investigational New Drug application with the FDA, backed by a solid funding runway exceeding 13 quarters.

Cokal Limited advanced its Indonesian metallurgical coal projects in Q1 2025 with key financing secured by joint venture partner PT Petrindo, completion of critical infrastructure, and a strategic US$7 million prepayment facility. These developments underpin Cokal’s strategy to ramp up production while reducing costs amid challenging market conditions.